Two cases are presented with coronavirus disease 19 (COVID-19)-related hiccups: one during initial presentation and one 10 days after COVID-19 diagnosis. Hiccups in both patients were resistant to treatment and responded only to chlorpromazine. COVID-19 patients may present with hiccups and also may have hiccups after treatment. Resistant hiccups without any underlying disease other than COVID-19 should be considered in association with COVID-19 and may respond well to chlorpromazine.
Address correspondence to Hande Ikitimur, Biruni University Medical Faculty Hospital, Eski Londra Asfalti, No: 10, Besyol, Kucukcekmece, Istanbul, Turkey. E-mail: email@example.com
Authors’ addresses: Hande Ikitimur, Department of Pulmonary Diseases, Biruni University Medical Faculty, Istanbul, Turkey, E-mail: firstname.lastname@example.org. Betul Borku Uysal, Department of Internal Medicine, Biruni University Medical Faculty, Istanbul, Turkey, E-mail: email@example.com. Barıs Ikitimur, Department of Cardiology, Cerrahpasa School of Medicine, University-Cerrahpasa, Istanbul, Turkey, E-mail: firstname.lastname@example.org. Sefika Umihanic, Department of Oncology, Clinic for Pulmonary Disease, Tuzla, Bosnia and Herzegovina, E-mail: email@example.com. Jasmina Smajic, Anaesthesiology and Resuscitation Clinic, Intensive Care Unit University Medical Center Tuzla, Tuzla, Bosnia and Herzegovina, E-mail: firstname.lastname@example.org. Rahima Jahic, Clinic for Infectious Diseases, Tuzla, Bosnia and Herzegovina, E-mail: email@example.com. Ayhan Olcay, Department of Cardiology, Istanbul Aydın University, Istanbul, Turkey, E-mail: firstname.lastname@example.org.